B

셀로맥스사이언스

471820KOSDAQ기타 식품 제조업

57.5 / 100

Reference Date: 2026-04-13

Financial Score22.0 / 40
News Sentiment12.5 / 25
Momentum13.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Slightly up 5.0% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Selomax Science, established in 2014, is a company specializing in the development and distribution of high-quality health functional foods using natural ingredients sourced through global partnerships. It distributes products through pharmacies and online platforms, with 6,881 affiliated pharmacies as of 2025, and is expanding into Asian markets. The company also develops a diverse range of general pharmaceuticals and cosmetics.

Number of Employees

52people

Average Salary

43.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
19.51Industry Average 13.533.0Point

Higher than industry avg (caution)

PBR
1.24Industry Average 0.641.0Point

1.9x industry avg (risky)

ROE
6.49Industry Average 2.727.0Point

2.4x industry avg (excellent)

Debt Ratio
2.61Industry Average 11.918.0Point

Half of industry avg (excellent)

Trend 2024~20253.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲2.6% (1-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼48.5% (1-year basis)

ROE Trend
2.0 / 4

Avg ROE 8.4% (declining, 2yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (23%)

Current 5,150Won52-week high 6,98052-week low 4,595
1-month return4.0Point

1m +4.99% (slight rise)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-04-07
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-06
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-06
  • Neutral자기주식처분결과보고서2026-04-06
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-06